KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Asset Writedowns and Impairment (2016 - 2026)

West Pharmaceutical Services has reported Asset Writedowns and Impairment over the past 9 years, most recently at $300000.0 for Q1 2026.

  • Quarterly Asset Writedowns and Impairment changed 0.0% to $300000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $11.7 million through Mar 2026, up 67.14% year-over-year, with the annual reading at $11.7 million for FY2025, 60.27% up from the prior year.
  • Asset Writedowns and Impairment was $300000.0 for Q1 2026 at West Pharmaceutical Services, down from $7.3 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $7.3 million in Q4 2025 and troughed at $200000.0 in Q2 2022.
  • The 5-year median for Asset Writedowns and Impairment is $1.4 million (2022), against an average of $2.2 million.
  • Biggest five-year swings in Asset Writedowns and Impairment: tumbled 80.0% in 2024 and later surged 1166.67% in 2025.
  • Tracing WST's Asset Writedowns and Impairment over 5 years: stood at $4.6 million in 2022, then crashed by 41.3% to $2.7 million in 2023, then soared by 100.0% to $5.4 million in 2024, then skyrocketed by 35.19% to $7.3 million in 2025, then tumbled by 95.89% to $300000.0 in 2026.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at $300000.0, $7.3 million, and $300000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.